Clinical Trial Update: Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial reports that glimepiride demonstrated superior efficacy to sitagliptin in treatment-naïve adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Januvia (sitagliptin)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED